A detailed history of Welch Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Welch Group, LLC holds 6,548 shares of LLY stock, worth $4.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
6,548
Previous 6,339 3.3%
Holding current value
$4.9 Million
Previous $5.74 Million 1.08%
% of portfolio
0.25%
Previous 0.28%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$772.14 - $960.02 $161,377 - $200,644
209 Added 3.3%
6,548 $5.8 Million
Q2 2024

Jul 17, 2024

BUY
$724.87 - $909.04 $288,498 - $361,797
398 Added 6.7%
6,339 $5.74 Million
Q1 2024

Apr 09, 2024

BUY
$592.2 - $792.28 $380,192 - $508,643
642 Added 12.12%
5,941 $4.62 Million
Q4 2023

Jan 22, 2024

SELL
$525.19 - $619.13 $114,491 - $134,970
-218 Reduced 3.95%
5,299 $3.09 Million
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $20,865 - $28,766
48 Added 0.88%
5,517 $2.96 Million
Q2 2023

Jul 18, 2023

SELL
$350.74 - $468.98 $89,789 - $120,058
-256 Reduced 4.47%
5,469 $2.56 Million
Q1 2023

Apr 13, 2023

SELL
$310.63 - $364.82 $44,730 - $52,534
-144 Reduced 2.45%
5,725 $1.97 Million
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $14,469 - $16,860
45 Added 0.77%
5,869 $2.15 Million
Q3 2022

Oct 13, 2022

SELL
$296.48 - $337.87 $180,852 - $206,100
-610 Reduced 9.48%
5,824 $1.88 Million
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $114,998 - $142,913
490 Added 8.24%
6,434 $1.84 Million
Q4 2021

Jan 26, 2022

SELL
$224.85 - $279.04 $42,271 - $52,459
-188 Reduced 3.07%
5,944 $1.64 Million
Q1 2021

Apr 23, 2021

BUY
$164.32 - $212.72 $139,836 - $181,024
851 Added 16.11%
6,132 $1.15 Million
Q4 2020

Jan 25, 2021

BUY
$130.46 - $172.63 $74,884 - $99,089
574 Added 12.19%
5,281 $892,000
Q3 2020

Oct 28, 2020

SELL
$146.22 - $169.13 $14,622 - $16,913
-100 Reduced 2.08%
4,707 $697,000
Q2 2020

Jul 22, 2020

BUY
$136.42 - $164.18 $150,334 - $180,926
1,102 Added 29.74%
4,807 $789,000
Q1 2020

Apr 28, 2020

BUY
$119.05 - $147.35 $185,718 - $229,866
1,560 Added 72.73%
3,705 $514,000
Q4 2019

Jan 24, 2020

BUY
$106.92 - $132.43 $37,956 - $47,012
355 Added 19.83%
2,145 $282,000
Q2 2019

Jul 11, 2019

SELL
$110.79 - $129.32 $3,877 - $4,526
-35 Reduced 1.92%
1,790 $198,000
Q1 2019

Apr 15, 2019

BUY
$111.31 - $131.02 $74,577 - $87,783
670 Added 58.01%
1,825 $237,000
Q4 2018

Jan 10, 2019

BUY
$105.9 - $118.64 $847 - $949
8 Added 0.7%
1,155 $134,000
Q3 2018

Nov 01, 2018

BUY
$85.86 - $107.31 $98,481 - $123,084
1,147 New
1,147 $123,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Welch Group, LLC Portfolio

Follow Welch Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.